Boehringer Ingelheim · 2 weeks ago
Material and Analytical Sciences - Intern
Boehringer Ingelheim is a global leader in the pharmaceutical industry, and they are seeking a talented and innovative Intern to join their Material and Analytical Sciences department. In this role, the intern will work on developing workflows to identify optimal critical quality attributes of tablets for desired drug product performance based on material property predictive tools.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
He/she will be involved routine drug product development processes
Establish correlations between material property and predictive model tuning parameters
Develop new insights and summarize findings for department seminar
Qualification
Required
Must be a current graduate or advanced degree student in good academic standing
Student must be enrolled at an accredited college or university for the duration of the internship
Overall cumulative minimum GPA from last completed quarter/semester 3.0 GPA (on a 4.0 scale) preferred
Major or minor in related field of internship
Graduate and advanced degree students must have completed at least 9 credit hours at current college or university
Good understanding of pharmaceutical material science
Must be legally authorized to work in the United States without restriction
Must be willing to take a drug test and post-offer physical (if required)
Must be 18 years of age or older
Preferred
Overall cumulative minimum GPA from last completed quarter/semester 3.0 GPA (on a 4.0 scale) preferred
Prior experience in Stylone compaction simulator is preferred
Fluency in coding using Python or Matlab is a plus
Benefits
Competitive compensation and benefit programs
Programs and groups that ensure your health and wellbeing are looked after
Company
Boehringer Ingelheim
Boehringer Ingelheim is a group of pharmaceutical companies that focuses on prescription medicines and animal health. It is a sub-organization of Boehringer Ingelheim.
Funding
Current Stage
Late StageLeadership Team
Recent News
2026-01-07
Company data provided by crunchbase